Can Alnylam Pharmaceuticals Stock Recover If Markets Fall?
Alnylam Pharmaceuticals (ALNY) stock is down 11.3% in 5 trading days. The recent slide reflects renewed concerns around insider selling and widening net losses, but sharp drops like this often raise a tougher question: is the weakness temporary, or a sign of deeper cracks in the story?
Before judging its downturn reslience, let’s look at where Alnylam Pharmaceuticals stands today.
- Size: Alnylam Pharmaceuticals is a $54 Bil company with $3.2 Bil in revenue currently trading at $412.63.
- Fundamentals: Last 12 month revenue growth of 53.2% and operating margin of 8.2%.
- Liquidity: Has Debt to Equity ratio of 0.02 and Cash to Assets ratio of 0.56
- Valuation: Alnylam Pharmaceuticals stock is currently trading at P/E multiple of 1375.9 and P/EBIT multiple of 460.0
- Has returned (median) -0.9% within a year following sharp dips since 2010. See ALNY Dip Buy Analysis.
These metrics point to a Strong operational performance, alongside Very High valuation – making the stock Relatively Expensive. For details, see Buy or Sell ALNY Stock
That brings us to the key consideration for investors worried about this fall: how resilient is ALNY stock if markets turn south? This is where our downturn resilience framework comes in. Suppose ALNY stock falls another 20-30% to $289 – can investors comfortably hold on? Turns out, the stock saw an impact slightly worse than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.
- Earn 9.4% Today or Buy CROX 40% Cheaper – It’s a Win-Win
- Triggers That Could Ignite the Next Rally In Applied Materials Stock
- Palantir Technologies Stock Can Sink, Here Is How
- Cash Machine Trading Cheap – Webull Stock Set to Run?
- High Margins, 43% Discount: Buy Adobe Stock Now
- Ten-Year Tally: Accenture Stock Delivers $60 Bil Gain
2022 Inflation Shock
- ALNY stock fell 42.5% from a high of $209.29 on 14 October 2021 to $120.42 on 11 May 2022 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 3 August 2022
- Since then, the stock increased to a high of $491.22 on 20 October 2025 , and currently trades at $412.63
| ALNY | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -42.5% | -25.4% |
| Time to Full Recovery | 84 days | 464 days |
2020 Covid Pandemic
- ALNY stock fell 30.5% from a high of $133.99 on 12 February 2020 to $93.12 on 12 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 17 April 2020
| ALNY | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -30.5% | -33.9% |
| Time to Full Recovery | 36 days | 148 days |
2018 Correction
- ALNY stock fell 57.8% from a high of $148.54 on 20 March 2018 to $62.67 on 24 December 2018 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 19 June 2020
| ALNY | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -57.8% | -19.8% |
| Time to Full Recovery | 543 days | 120 days |
2008 Global Financial Crisis
- ALNY stock fell 58.6% from a high of $36.55 on 9 October 2007 to $15.14 on 9 March 2009 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 3 July 2013
| ALNY | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -58.6% | -56.8% |
| Time to Full Recovery | 1577 days | 1480 days |
Feeling jittery about ALNY stock? Consider portfolio approach.
Portfolios Beat Stock Picking
Stocks soar and sink – the key is staying invested. A balanced portfolio keeps you in the market, boosts gains and reduces single stock risk
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.